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Summary 
Strain C.B17 scidAcid (SCID) mice, which lack functional T and B lymphocytes, show heightened 
susceptibility to the induction of thymic lymphomas by x-irradiation. Susceptibility is highest 
in thymus-chimeric SCID-BL mice (thymectomized  SCID mice bearing a C57BL thymus graft). 
All SCID-BL lymphomas originate in the cells of the thymic graft (C57BL type) and lack murine 
leukemia virus expression.  Both SCID and SCID-BL lymphomas are phenotypically CD4-8 + 
and/or CD4+8 + , but only the SCID-BL tumors express CD3. Injection of C57BL or BALB/c 
bone marrow into irradiated SCID-BL mice prevents lymphoma development, but SCID marrow 
is completely ineffective. The results suggest that the scid condition enhances the activity of 
a putative lymphomagenic agent induced in the bone marrow by x-irradiation and that C57BL 
thymic cells are highly sensitive targets.  Moreover, the failure of SCID bone marrow to protect 
against lymphomagenesis vs. the efficacy of marrow from immunocompetent donors points to 
involvement of T  or B lineage cells in this process. 
E 
xposure to ionizing radiation in fractionated doses leads 
to a high frequency of T cell lymphomas in mice of sus- 
ceptible strains  (1, 2). Thymocytes are the target for neo- 
plastic transformation, but an early, critical event appears to 
occur in the bone marrow. Thus, in C57BL mice, grafting 
a nonirradiated, histocompatible thymus in previously thymec- 
tomized, irradiated hosts produces lymphomas of graft origin, 
indicating an event in the irradiated host that promotes the 
neoplastic transformation of grafted thymic lymphocytes. Fur- 
thermore, transfer of bone marrow cells from irradiated donors 
to nonirradiated Thy-1 congenic mice produces thymic lym- 
phomas of host origin (3, 4), demonstrating that irradiated 
marrow is suflficient to transfer a lymphomagenic agent(s). 
A murine leukemia virus (RadLV), 1 obtained from cell-free 
extracts  of radiation-induced lymphomas (5),  was initially 
thought to be the agent being transmitted from the irradi- 
ated bone marrow to the thymus. However, since RadLV is 
recovered from only 5-10%  of tumors (6),  the hypothesis 
was advanced that radiation activates a non-murine leukemia 
virus (non-MuLV) unidentified lymphomagenic  agent in the 
1 Abbreviations used in this paper: MuLV, murine leukemia virus; RadLV, 
radiation leukemia virus. 
bone marrow, that the agent is transmitted to thymic target 
cells, and that it causes their eventual neoplastic transforma- 
tion (4). 
Conversely, shielding the bone marrow of irradiated mice 
or injecting exogenous marrow in whole-body irradiated mice 
has been shown to prevent lymphoma development (7). To 
learn more of the interactions between thymus and bone 
marrow in the radiogenesis  of lymphomas, we have made 
use of mice of the BALB/c substrain C.B-17 scidAcid (here- 
after SCID), in which an autosomal recessive mutation on 
chromosome 16 is associated with aberrant and nonproduc- 
tive rearrangements in Ig and TCR genes. This leads to the 
absence of functional B and T lymphocytes and the manifesta- 
tion of the sdd syndrome (8). In addition, multiple organ 
systems in SCID mice are hypersensitive  to the cell-killing 
effects of radiation, apparently as a result of defective capacity 
to repair DNA double-strand breaks (9, 10). This character- 
istic, together with their lack of mature lymphocytes, makes 
SCID mice interesting subjects for the study of the lymphoma- 
genic effect of ionizing radiation. Here, we present evidence 
that  the  scid  syndrome enhances the effectiveness of the 
presumptive lymphomagen, and that it abolishes the ability 
of normal bone marrow cells to prevent lymphoma devel- 
opment. 
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Mice.  The mice used in this study were obtained from specific 
pathogen-free stock maintained by the Department of Compara- 
tive Medicine, Stanford University, SCID mice were put on a 
regimen of the antibiotics trimethoprim and sulfamethoxazole,  as 
described (11), at the time experimental procedures were initiated. 
They were thymectomized when 4-5 wk old, grafted under the 
renal capsule with a whole thymus from a neonatal donor  10 d 
later, and exposed to 1.75 Gy whole-body x-irradiation 2 wk there- 
after. In another group, the mice were irradiated immediately be- 
fore grafting. Mice used for studies of  bone marrow protection were 
either irradiated with a 3-ram-thick lead shield over one femur or 
received 107 bone marrow cells from unirradiated donors intrave- 
nously within 2 h after exposure to whole-body x-radiation. 
Antibodies andlmmunologicalAssays.  The antibodies  used in this 
study were: a polyvalent, broadly reactive rat anti-MuLV serum 
that binds to ecotropic, leukemogenic,  as well as nonleukemogenic, 
routine retroviruses (12); rat mAb to the mouse antigen 1Cll, a 
marker of thymic lymphomas,  preleukemic thymocytes,  and prolifer- 
ating progenitor cells (13); mouse mAb 19XE5 (anti-Thy-l.1), ob- 
tained from Dr. R. Nowinski, Genetic Systems  Inc. (Seattle,  WA); 
rat mAbs 53-2.1 (anti-Thy-l.2), GK1.5 (anti-CD4), and 53-6.72 
(anti-CD8), obtained from the American Type Culture Collection 
(Rockville, MD); and hamster mAb 145-2Cll (anti-mouse CD3), 
purchased from Boehringer Mannheim Corp. (Indianapolis, IN). 
The antibodies were used either unmodified or conjugated to bi- 
otin or fluorochromes. Fluorochrome-conjugated second-stage re- 
agents, purchased from Caltag Laboratories (South San Francisco, 
CA) were used to detect antibody binding, and the phenotype of 
stained thymocytes was analyzed  in a FACS  |  equipped with a dual 
laser (Becton  Dickinson & Co., Mountain View, CA). The staining 
procedure and the analysis  of cell populations have been described 
in detail (13). 
Unidirectional MLR.  Thymocytes from the thymus in situ or 
from  a  thymic  graft  (5  x  10  s cells) were mixed with equal 
numbers of irradiated (2 Gy) stimulator cells and maintained in 
culture for 3 d, in quadruplicate  wells. The cultures were then pulsed 
for 18 h with 1/zCi [3H]thymidine, and proliferation of the re- 
sponder cells was determined by measuring counts/min in a scin- 
tiUation counter. 
Results 
SCID Mice Are Highly Sensitive to x-Ray Induction of Thymic 
Lymphomas.  The conventional lymphomagenic regimen of 
fractionated whole-body exposure to x-irradiation, which is 
optimal for the induction of lymphomas in mice of strain 
C57BL (1.75 Gy on four consecutive weeks), was not toler- 
ated by SCID mice and treatment was therefore reduced to 
a single 1.75-Gy exposure.  13 of 25 irradiated mice (52%) 
developed  thymic lymphomas, whereas dinical evidence of 
spontaneous thymic lymphoma in our SCID mouse colony 
has been observed in only "~3% of animals in the age range 
of 5-12 mo (Table 1). The phenotypic profiles of  normal SCID 
thymocytes, and of those of representative thymomas induced 
by radiation and arising spontaneously, are shown in, respec- 
tively, Fig.  1, A, B, and C. A significant difference between 
normal and neoplastic thymocytes is seen in the patterns of 
CD4 and CD8 expression.  Normal SCID thymocytes are es- 
sentially (>96%)  CD4-8-,  as  reported  (14, 15). In  the 
radiation-induced lymphomas, if quadrants are drawn as for 
the normal thymocytes, there appear to be CD4 +  8 + as well 
as CD4-8 + cells; nevertheless,  the staining pattern clearly 
depicts a unimodal CD41~ + population, rather than two 
distinct subsets.  The cells are  CD3-,  indicating that  the 
CD4-/1~  + phenotype corresponds  to the transitional inter- 
mediate between  the  CD4-8-  and CD4+8 +  stages  in  a 
normal thymus (16). The spontaneous lymphoma consists 
of two distinct populations,  the larger one CD4+8 +,  the 
smaller one CD4+81~  possibly a transitional intermediate in 
the direction of the CD4+8 -  phenotype, as suggested by 
the presence of a small number of CD3 + cells. Such emer- 
gence of differentiated T  cells has been described in aging, 
leaky SCID mice, and is frequently accompanied by neoplastic 
transformation (8,  14). As in C57BL lymphomas (13), the 
1Cll antigen is expressed at high levels by a majority of tumor 
cells, spontaneous as well as induced. It is noteworthy that 
the majority ('~83%) of normal adult SCID thymocytes are 
Table  1.  Radiation Lxrapkomagenesis in SCID Mice 
Treatment 
Thymus 
Thymectomy  graft  Irradiation 
Lymphomas 
Median  Genetic 
Incidence (%)  latency  origin*  MuLV~ 
No  None  None 
No  None  1.75 Gy  x  1 
Yes  BALB/c  1.75 Gy  x  1 after grafting 
Yes  BL/1.1  1.75 Gy  x  1 after grafting 
Yes  BL/1.1  1.75 Gy  x  1 before grafting 
Yes  BL/1.1  None 
d 
7/200  (3.5)  -$  ND  None 
13/25  (52)  206  ND  None 
8/24 (33)  166  ND  None 
22/24  (92)  92  BL/1.1  None 
20/23  (87)  142  BL/1.1  None 
12/39  (31)  153  BL/1.1  None 
* Genetic origin determined  by Thy-1 allotype expressed on ceUs. 
* Presence of MuLV determined by expression of MuLV-associated antigens. 
$  Mice in this group were stock. Age range at death from lymphoma  was 5-12 too. 
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Figure 1.  Phenotype  of normal and neoplastic SCID 
thymocytes.  (A) Untreated 6-wk-old SCID mouse; (/3) 
thymic  lymphoma  in irradiated SCID mouse; (C) spon- 
taneous SCID thymic lymphoma. In the tingle-color 
fluorescence  histograms,  fluorescence  intensity  is presented 
on the x-axis (log scale), and the relative  number  of cells 
is on the y-axis. Cells stained  with mAb 1Cll were  coun- 
terstained  with Texas red (TR)-conjugated  anti-rat anti- 
body. Fluorescence  intensity to the right of the arrows 
specifies 1Cll hi (5-10 times higher than background 
fluorescence);  the percentage  of 1Cll bi cells is indicated. 
Broken  lines show  background  fluor"~r~ace  obtained  with 
an isotype-matehed,  irrelevant  rat mAb. For analysis of 
CD3 expression,  cells  were  stained  with anti-CD3 (FITC); 
control cells were treated with FITC (broken lines). For 
two-color  analysis,  cells  were  stained  with anti-CD4  (PE) 
and anti-CD8 (TK). The number  of  contour  lines drawn 
in a particular  area  depict the frequency  of  cells  exhibiting 
given levels  of  fluorescence.  The quadrants show the per- 
centages of the total population with the phenotypes 
CD4-8-  (lower left), CD4+8  -  (upper left), CD4+8  * 
(upper right), and CD4-8 + (lotuer  right). 
also  1Cll hi,  in  contrast  to  only  10--20%  (the  immature 
subset) of normal C57BL thymocytes (12; and see Figs. 3C 
and  D),  another  indication  of the  immaturity  of SCID 
thymocytes. 
Characterization of Thrmic Graft L•mphomas  in SCID-BL 
M/ce  Definition of the relative roles of cells from the thymus 
and the bone marrow in the genesis of radiation-induced lym- 
phomas requires that the origin of the cells be identifiable. 
This can be accomplished by using thymus-chimeric mice, 
in which the thymus in situ is replaced by a genetically dis- 
tinct thymic graft at an ectopic site,  e.g., a parental strain 
thymus in an F1 host (3) or a Thy-l-congenic thymic graft 
(4). SCID mice, thymectomized to prevent the development 
of spontaneous  or in  situ  radiogenic thymomas, received 
thymic implants from immunocompetent neonatal donors 
under the renal capsule,  and were subsequently irradiated. 
The resulting tumors are characterized in Table 1. Initially, 
thymus grafts of the BALB/c parental strain were used to 
determine the susceptibility to radiation lymphomagenesis 
of an immunocompetent thymus within the scid environ- 
ment. 8 of 24 grafted and irradiated mice (33%) developed 
lymphomas involving the graft, an incidence that is statisti- 
cally similar to that observed in intact, irradiated SCID mice 
(52%, see above). Next, SCID-BL/1.1 mice were constructed 
by implanting C57BL/Ka/Thy-l.1 (BL/1.1) thymic grafts 
in thymectomized SCID recipients, so that cells of graft origin 
(Thy-l.1) could be distinguished from those of host orion 
(Thy-l.2).  In this group, the incidence of radiogenic lym- 
phomas was a striking 22 of 24 mice (92%), after a relatively 
short latent period (92 d). All lymphomas were of graft donor 
(Thy-l.1) origin. The possibility of MuLV involvement in 
the etiology of the tumors was tested by immunofluorescence 
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assays for cytoplasmic viral antigens. Lymphoma cells were 
used directly, and in a more sensitive infectious center test, 
which allows detection of as few as one infected cell in 106 
(17). For this assay, lethally irradiated (5.0 Gy) tumor cells 
were added to a culture of highly permissive BL/RL12-NP 
indicator cells  (18),  and after 10 d  (16-20 cell doublings), 
these were tested for expression of MuLV p30 by immuno- 
fluorescence using a rat antiserum as described (12).  Infec- 
tious MuLV was not detected in either assay (data not shown). 
Symptoms of a graft-vs.-host reaction (GvHR) in the chimeras, 
e.g., failure to thrive, splenomegaly, MuLV activation (19-21), 
which might be expected as a result of H-2 incompatibility, 
were not observed. To further verify the absence ofa GvHR, 
a tmidirectional MLR assay was performed, measuring prolifer- 
ation of thymic graft cells from SCID-BL/1.1 mice and con- 
trol BL/1.1 thymocytes on coculture with irradiated autolo- 
gous cells, SCID spleen cells, and third-party (C3H) spleen 
cells. The results (Fig. 2) point to two distinct phenomena. 
One is that SCID spleen cells are not effective stimulators, 
since they evoked only one-fourth the response induced by 
C3H spleen cells in normal BL/1.1  thymocytes. This may 
stem from the reduced presence of stimulating cells or of lym- 
phokines in the mixed culture, as a result of the absence of 
T and B cells in the SCID spleen. A further conclusion sug- 
gested by the results is that thymic graft cells in SCID-BL/1.1 
mice have been tolerized to their host,  since they did not 
mount even a weak response to SCID spleen cells, while re- 
taining full reactivity to third-party cells. The phenotype of 
the graft lymphomas is shown in Fig. 3 A.  The majority 
of cells  (>87%)  expressed elevated levels  of the transfor- 
mation-associated antigen 1Cll.  The most commonly ob- 
served phenotypes consisted of a majority of cells distributed Fvs C3H 
BL/1.1 Thyme:st /V ' SCID  Graft in SCID 
Lvs Self 
.o,,;::,m~  i.sc,o 
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Figure 2.  Lack ofGvHR ofthymic graft lymphocytes in SCID-BL/1.1 
chimeras. BL/1.1 thymic graft cells and BL/1.1 thymocyte controls (5  x 
105 cells/well) were cultured with equal numbers of radiation-killed au- 
tologous cells, SCID, and C3H spleen cells, and pulsed with [3H]thymi- 
dine. Results are expressed  as mean isotope incorporation  _+  SE. 
among the CD4- 8 + and CD4 +  8 + populations in varying 
proportions. Similar patterns have been observed in primary 
radiation-induced C57BL thymic lymphomas (Sen-Majumdar 
et al., manuscript submitted for publication).  In those tumors, 
the CD4- 8 + and CD4 +  8 + subsets were obtained separately 
by FACS  |  sorting and passaged intrathymicaUy  in Thy-1 con- 
genic  recipients.  The  resulting  tumors  again  had  both 
CD4- 8 + and CD4 +  8 + components, regardless  of parental 
Table  2.  Prevention  of Radiogenic Lyraphomas in SCID-BL 




Protection  protocol  Incidence (%)*  latency 
d 
None*  22/24  (92)  92 
Femur  shielded  19/21  (90)  112 
SCID  marrow  injectedS  15/15  (100)  115 
BALB/c  marrow  injectedS  6/27  (22)  111 
C57BL  marrow  injectedS  1/13  (8)  109 
* All lymphomas were of thyrnic graft donor (BL/1.1) origin, as deter- 
mined by Thy-1 allotype, and free of MuLV-associated antigens. 
From Table 1. All mice were irradiated (1.75  Gy  x  1) after implan- 
tation of the thymic graft. 
S 107 bone marrow cells from untreated mice injected intravenously af- 
ter irradiation. 
tumor phenotype. From this, we infer that the observed bi- 
modal populations in the neoplastic grafts probably repre- 
sent phenotypic variants of a single clone, rather than two 
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Figure 3.  Phenotype of normal and neoplastic thymic 
grafts in SCID-BL/1.1 mice. (A) Thymic graft lymphoma 
in an irradiated SCID-BL/1.1 mouse; (B) thymic graft lym- 
phoma in an irradiated SCID-BL/1.1 mouse injected with 
SCID bone marrow; (C) normal phenotype resulting from 
injection of C57BL (Thy-l.2) bone marrow; (D) normal 
phenotype of a C57BL thymus for comparison with C. 
The staining protocol was as described  in Fig. 1. 
402  Radiation-induced Lymphomas in SCID Mice distinct clones. Fewer cells were CD4-8-  and very few or 
none were CD4+8 -.  Unlike the radiation-induced SCID 
tumors, the SCID-BL/1.1  graft lymphomas were CD3 +. 
Subsets with, respectively, high and low expression of CD3, 
which are seen in nonleukemic thymus (Fig. 3, C and D), 
were not apparent. 
Influence of  the Immunocleficient  scid  Environment  on Lymphoma. 
genesis.  Irradiation of the graft itself was not necessary for 
the development  oflymphomas. When the allogeneic thymus 
was implanted subsequent to irradiation of the host, evidence 
of GvHR was again not observed;  tumors developed after 
a somewhat longer latent period than in the previous experi- 
ment (142 d), in 20 of 23 mice (87%), and all were of thymus 
graft donor origin (Table 1). Their phenotypes were similar 
to those seen in tumors of mice irradiated after grafting. The 
persistence  of a high frequency of lymphomas in this pro- 
tocol contrasts with their low incidence (20-25%) in thymec- 
tomized C57BL/Ka mice given a histocompatible thymic graft 
at the end of a lymphomagenic course of x-radiation (3, 4). 
The results suggest the possibility that SCID-BL/1.1 chimeras 
have an intrinsic propensity to develop lymphomas. There- 
fore an additional group of these mice was maintained without 
irradiation. In this group, 12 of 39 mice (31%) developed 
lymphomas, all of graft-donor origin (Table 1), suggesting 
that mere residence in a scid environment may promote the 
neoplastic transformation of C57BL/Ka thymocytes. 
SCID Bone Marrow Uniquely Cannot Prevent  Radiation-induced 
Thymic Lymphomas.  In irradiated C57BL/Ka mice, shielding 
a femur during irradiation or injecting normal histocompat- 
ible bone marrow after its completion has been shown to 
greatly reduce the frequency of lymphomas (7, 22). The mech- 
anism of protection is not clear, but since thymic reconstitu- 
tion by donor marrow-derived cells is consistently observed 
in protected mice, repopulation of the thymus may be a cru- 
cial step. In SCID mice, the progeny of hemopoietic  precursors 
in the marrow are not capable of normal lymphoid differen- 
tiation. Hence, it was of interest to examine the capacity of 
SCID bone marrow to prevent the development oflymphomas 
in irradiated mice. SCID-BL/I.1 mice were either irradiated 
with one femur shielded or received bone marrow cells from 
unirradiated SCID donors immediately after whole-body ir- 
radiation. There was no evidence of protection; the incidence 
oflymphomas was 91% for the femur-shielded mice and 100% 
for those injected with SCID bone marrow. The tumor calls 
were Thy-l.1, i.e., derived from the thymic graft (Table 2). 
Bone marrow from untreated adult BALB/c and C57BL/Ka 
donors was used next. Evidence of incompatibility between 
the irradiated SCID-BL/1.1 mice and the injected marrow 
was not observed.  However, the incidence of lymphomas in 
these groups was reduced to 22% and 8%, respectively (Table 
2).  The residual lymphomas were of thymus graft origin, 
but in all protected mice, analyzed concurrently with mice 
not receiving bone marrow, thymocytes were Thy-l.2 (data 
not  shown),  i.e.,  the  thymus was  repopulated by donor 
marrow-derived cells. In protected mice (Fig. 3 C), the level 
of 1Cll expression on thymic graft cells was approximately 
the same as that seen on normal thymocytes (Fig. 3 D), and 
that of the differentiation markers CD3, 4, and 8 was typical 
of normal thymic subsets as well (Fig. 3, C and D). In the 
unprotected thymus of mice injected with SCID bone marrow, 
however, the cellular phenotype (Fig. 3 B) was similar to that 
ofthymocytes in the irradiated,  uninjected group (Fig. 3 A). 
Discussion 
Human congenital immunodeficiency syndromes are fre- 
quently associated with a high incidence of leukemias and 
lymphomas of varied histopathology and undefined etiology 
(23-25). The development ofT cell lymphomas has been de- 
scribed in SCID mice as well, among the few leaky individ- 
uals in which productive TCR gene rearrangement has oc- 
curred (8, 26). In this study, we have examined the sensitivity 
of SCID mice to the lymphomagenic effect of ionizing radi- 
ation. A single,  low dose of x-radiation sufficed to induce 
a moderate incidence of thymic lymphomas, which were 
CD4-8 + and CD4+8 +,  but CD3-.  In C57BL/Ka mice, 
irradiation  has  been  observed  to  induce  the  entry  of 
CD3 +  4-8-  target cells into an aberrant differentiation path- 
way,  resulting  in  the  development  of  CD3+4-8 +  and 
CD3 +4 +8 § lymphomas (Sen-Majumdar et al., manuscript 
submitted for publication). Radiation-induced lymphomas 
in SCID mice exhibited similar CD4/CD8 phenotypes, al- 
though, presumably through failure of TCR gene rearrange- 
ment, differentiation did not proceed past the pre-TCK stage. 
Shores et al.  (14) reported that the presence in the SCID 
thymus  of TCR +  cells, as  a  result  of either  the  leaky 
phenomenon or the introduction of bone marrow from non- 
scid donors, promotes the differentiation of SCID thymo- 
cytes into CD4-8+TCK -  and CD4+8+TCR -  ceils. The 
results presented here suggest that radiation may exert a similar 
effect in the absence of TCR + cells. In irradiated SCID-BL 
chimeric mice, the frequency of lymphomas was greatly in- 
creased and the latent period shortened, particularly when 
the graft was itself irradiated,  These results likely reflect the 
known high susceptibility of C57BL/Ka thymic cells to neo- 
plastic transformation, but the possibility must be consid- 
ered that neoplastic transformation may have been the conse- 
quence of a GvHR (19, 20).  However, this is an unlikely 
alternative,  since none of the described symptoms of GvHR 
(19-21) were observed in the mice, exposure to SCID spleen 
cells did not induce a MLR in SCID-BL/1.1 thymic graft 
cells, and the administration of adult C57BL bone marrow, 
which should have provided additional effector cells, instead 
prevented the development of lymphomas. The data suggest 
several nonexclusive models of the roles of bone marrow and 
thymus in radiation lymphomagenesis. (a) If, as we have as- 
sumed (4), a lymphomagenic  agent is induced in the marrow 
by radiation and is transmitted to thymic targets,  then the 
scid syndrome may favor its induction and/or activity.  (b) 
Lymphomagenesis could alternatively be interpreted as the 
ultimate result of the residence of the thymus in a host envi- 
ronment that cannot supply the normal precursors needed 
for its continued maintenance. This stage is presumably reached 
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ation, but occurs after a single exposure in SCID hosts and 
even, to some extent, in the absence of radiation.  It might 
be speculated that, failing normal maturation of bone marrow 
precursors,  the thymus,  depleted of lymphocytes by radia- 
tion or grafting,  only manifests repopulation from within. 
Such an aberrant process could be self-perpetuating and pre- 
dispose to neoplastic transformation.  (c) Another possibility 
is that x-rays induce a transmissible lymphomagen that trans- 
forms thymic target cells, but that this process can be inter- 
rupted or controlled by the progeny of a subset of bone marrow 
cells. In normal mice, four doses of 1.75 Gy are required to 
inactivate that regulatory subset of cells, whereas little or no 
irradiation is required in the case of SCID mice. In this model, 
it becomes critical to determine the nature of the regulatory 
bone marrow-derived cells,  and why they are ineffective or 
absent in SCID mice. 
The prevention of radiation-induced lymphomagenesis by 
nonirradiated  endogenous or exogenous bone marrow cells 
is well documented (7,  22).  The mechanism of protection 
is not known; there may be repopulation of the thymus from 
precursors in the bone marrow or destruction  of incipient 
tumor cells by marrow-derived cells. The present study shows 
that the high incidence of lymphoma in irradiated SCID-BL 
mice was not altered by either shielding the femur or injecting 
marrow cells from normal SCID donors. However, injection 
of normal C57BL/Ka or BALB/c bone marrow did protect. 
Since NK cells are abundant and active in SCID mice (27), 
the ineffectiveness of SCID bone marrow  argues that  NK 
progenitors  are probably not a major factor in lymphoma 
prevention.  Indeed, it was shown earlier that bone marrow 
of C57BLbg/bg mice with low NK activity is as effective 
as that of C57BL donors in preventing radiation-induced lym- 
phomagenesis (28, and our unpublished results). If, alterna- 
tively, protection results from influx into the thymus of T 
lineage precursors from the unirradiated marrow, the inade- 
quacy of SCID bone marrow cells may be a consequence of 
the inability of their progeny to mature beyond the pre-TCR 
stages, and provides a first indication of the mechanism through 
which protection may occur. Whether it results from a failure 
of regulated maturation  (model b),  failure of development 
of a  unique  regulatory  cell,  presumably  a  TCR +  T  cell 
(model c), or some other unanticipated mechanism remains 
to be determined.  Several approaches to answer these ques- 
tions offer themselves, e.g., determination whether it is the 
scid mutation (the inability to rearrange antigen receptor genes) 
or the scid condition (the absence of mature T  and B cell 
populations) that (a) increases  susceptibility to radiogenesis 
of lymphomas,  and (b) causes the lack of protection by in- 
jected bone marrow. Perhaps the introduction of TCR trans- 
genes in various combinations onto the scid background can 
alter susceptibility to radiation and/or the protective poten- 
tial of bone marrow. The high frequency and short latency 
of lymphomagenesis in SCID-BL thymus-chimeric mice make 
these animals useful subjects for a better elucidation of the 
early events in the development of radiation-induced  lym- 
phoma and of the antineoplastic  activities of bone marrow cells. 
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